Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
Dapagliflozin Cuts Risk of Diabetes in Patients with Chronic Kidney Disease
June 25th 2021A prespecified analysis of DAPA-CKD presented at ADA 2021 suggests use of dapagliflozin reduced the incidence of type 2 diabetes by nearly 40% among patients with chronic kidney disease but without diabetes within the phase 3 trial.
Read More
Unmanaged Diabetes Linked to More Severe COVID-19, Longer Stays in Hospital
June 25th 2021While investigators found no differences in outcomes based on diabetes status alone, results indicated those who were not managing their diabetes had more severe outcomes and longer length of hospitalization from COVID-19.
Read More
Finerenone and SGLT2 Inhibitors Could Have Additive Effect on Kidney Protection
June 25th 2021Data from an analysis of FIDELIO-DKD suggests the renoprotective benefits of finerenone were consistent irrespective of SGLT2 inhibitor use and those using an SGLT2 inhibitor with finerenone resulted in greater UACR reductions.
Read More
Study Reviews Risk of Cardiovascular Disease, Outcomes in Patients with Nephrotic Syndrome
June 25th 2021A review of available data suggests patients with nephrotic syndrome were at a 19-fold greater risk of end-stage kidney disease and a 3-fold greater risk of acute coronary syndrome events.
Read More
Older Diabetes Patients Twice As Likely to Report Preventive Aspirin Use
June 23rd 2021An analysis of contemporary trends related to preventive aspirin use suggests older patients with diabetes were twice as likely to use preventive aspirin as their counterparts without diabetes, with many doing so despite it being considered inappropriate based on new guidance.
Read More
Early Life BMI Plays Role in Future Diabetes and CVD Risk, Regardless of Adult BMI
June 22nd 2021Using 24 years of follow-up data from more than 12k adolescents provides insight into the impact of childhood BMI z-scores on risk of adverse health outcomes, including development of diabetes and premature myocardial infarction, in adulthood.
Read More
Older Adults with Diabetes Twice as Likely to Use Aspirin for Prevention
June 21st 2021Using data from within NHANES from 2011-2018, investigators from Johns Hopkins University provide a comprehensive overview of the use of aspirin for primary and secondary prevention among older patients based on diabetes status.
Read More
Study Provides Overview of ESKD, Cardiovascular Risk in Adults with Nephrotic Syndrome
June 20th 2021Comparing data from patients with primary nephrotic syndrome to matched controls in a 1:100 ratio, investigators found these patients were at a 19-fold greater risk of end-stage kidney disease and a 3-fold greater risk of acute coronary syndrome events.
Read More
Study Details "Widespread" Use of Endocrine-Disrupting Chemicals in North American Cosmetic Products
June 17th 2021A study assessing levels of flourine in cosmetic products available in the US and Canada suggests many of these products could contain levels of chemicals that, over time, could cause harm.
Read More
GOULD Registry Details Subpar Levels of Intensifying Lipid-Lowering Therapies in ASCVD Patients
June 17th 2021Analysis of 2-year data from the GOULD Registry indicates new strategies are needed to address the suboptimal levels of lipid-lowering therapy intensification among patients with ASCVD and increased LDL-C.
Read More
Randomized Trial Suggests There is "Nothing Special" About Effects of Intermittent Fasting
June 17th 2021A randomized trial comparing 3 dietary approaches, including 2 involving fasting, suggests the recently popularized approach does not provide any substantial benefits compared to a traditional diet.
Read More
Financial Burden of Cardiovascular Disease Equals or Exceeds Burden Imposed by Cancer
June 15th 2021A comparison of data from patients with cancer and ASCVD from a nationally representative survey suggests the financial burden of cardiovascular disease was similar to or exceeded the burden imposed by cancer.
Read More
Discussing Bariatric Surgery Linked to Increased Weight Loss Whether or Not Patients Undergo Surgery
June 15th 2021A retrospective analysis of data from more than 30k patients with severe obesity suggests having a discussion about bariatric surgery with a clinician resulted in greater weight loss, regardless of if they underwent a bariatric procedure, but fewer than 9% had these discussions.
Read More
'Metabolically Healthy' Obesity Still Puts Patients at Increased Risk of Adverse Health Outcomes
June 14th 2021Data from the UK Biobank cohort details the increased risk of adverse health outcomes, including the development of diabetes and heart failure, among patients considered to have metabolically healthy obesity.
Read More
Women with Common Endocrine Disorder at Increased Risk of Cardiovascular Disease Risk
June 13th 2021A recent review of data from within a major European-based database indicates women with PCOS were at a 26% greater risk of major adverse cardiovascular events when compared to matched controls without polycystic ovary syndrome.
Read More